Wołos, Agnieszka
Koszelewski, Dominik
Roszak, Rafał
Szymkuć, Sara
Moskal, Martyna
Ostaszewski, Ryszard
Herrera, Brenden T.
Maier, Josef M.
Brezicki, Gordon
Samuel, Jonathon
Lummiss, Justin A. M.
McQuade, D. Tyler
Rogers, Luke
Grzybowski, Bartosz A.
Article History
Received: 26 June 2020
Accepted: 3 February 2022
First Online: 27 April 2022
Competing interests
: A.W., R.R., S.S., M.M. and B.A.G. are consultants and/or stakeholders of Allchemy, Inc. Allchemy software is the property of Allchemy, Inc., USA. On Demand Pharmaceuticals (ODP) is planning to file for US Food and Drug Administration (FDA) approvals on the flow processes described in this study. All queries about access options to Allchemy, including academic collaborations, should be sent to saraszymkuc@allchemy.net. On Demand Pharmaceuticals inquiries can be sent to lrogers@ondemandpharma.com.